Body Iron Stores Increase Hepatic and Serum Lipid in Rats fed a Standard Western Diet by Ahmed, Umbreen et al.
  
Body Iron Stores Increase Hepatic and Serum 
Lipid in Rats fed a Standard Western Diet 
 
Umbreen Ahmed, Trevor G. Redgrave and Phillip S. Oates (ret) 
 
Abstract- The liver is the major site for lipoprotein processing 
and iron storage. Non-alcoholic fatty liver disease (NAFLD) is 
a broad spectrum of chronic liver disorder with progressive 
factors hypothesized to include impaired hepatic lipid 
metabolism and oxidative stress. Since iron produces oxidative 
stress, its excess may lead to lipid peroxidation and hepatocyte 
damage. We hypothesized that increased hepatic iron in rats 
fed a western diet would progress NAFLD. We determined the 
effect of variation in iron on plasma and hepatic lipids and 
oxidative stress in a rat model without pre-existing liver 
damage.  Rats were fed liquid diets in which 35% of the energy 
was fat and contained low (STD-), normal (STD) or twice the 
normal level (STD+) of iron. The STD+ group also received 
parenteral iron dextran injections. After 5 weeks liver and 
blood were taken for analysis. Serum cholesterol and non-
esterified fatty acids were increased in STD+ compared with 
STD group. Serum triglyceride in STD+ rats was increased 
compared with STD-. Histologically the STD+ group showed 
foci of macrovesicular lipid droplets, whereas hepatic 
triglyceride was decreased in STD-. Liver expression of lipid 
responsive gene (SREBP-2, SREBP-1c, HMG CoA reductase, 
7α hydroxylase, MTTP1), chemokine (MCP-1) and oxidative 
stress marker, haemoxygenase-1 mRNA were similar in all 
groups. There were significant increases in hepatic 
malondialdehyde and hydroxyalkenal in STD+ compared with 
STD group. The erythrocytes of STD+ were osmotically fragile 
compared with the STD group. Increased liver iron affects 
plasma and hepatic lipids and may progress NAFLD by 
impairing hepatic fat metabolism. 
Keywords- Dietary fat, iron, iron dextran, rat model, 
non-alcoholic fatty liver disease.  
 
1 Introduction 
Non-alcoholic fatty liver disease (NAFLD) is a 
common chronic liver disorder having a broad 
spectrum ranging from simple steatosis to cirrhosis. 
Non-alcoholic steatohepatitis (NASH) belongs within 
this spectrum and forms the borderline between a 
benign condition (steatosis) and a serious/morbid 
condition (cirrhosis) [1, 2]. NAFLD is classified into 
four types with types I and II considered benign 
conditions the onset of which is thought to involve 
increased lipid delivery and its impaired utilization. 
Progression of the disease from type II to III involves 
increased oxidative stress leading to lipid 
peroxidation then activation of pro-inflammatory 
cytokines, inflammation and parenchymal tissue 
replacement by connective tissue.   
 
Iron is an essential micronutrient because it binds 
oxygen and accepts and donates electrons, however 
too much iron produces oxidative stress. Lipids are 
sensitive to oxidative stress in the presence of oxygen 
and iron. The highly reactive hydroxyl radicals 
generated by the iron-mediated Fenton and Haber-
Weiss reactions [3, 4] react with polyunsaturated 
fatty acids in cell membranes yielding toxic 
hydroperoxides and aldehydes. Lipid peroxidation 
causes cell injury/death by impairing cell membrane 
integrity [5] and damaging cell organelles [6-8].  
 
The hepatocyte is the parenchymal cell of the liver. It 
stores most iron in the body [9] and functions in  de 
novo lipogenesis, secretion, uptake and degradation 
of lipoproteins. Given this, the hepatocyte may be 
damaged if iron and lipids accumulate [10, 11]. Iron 
overload is closely associated with lipid metabolic 
disorders that lead to the development of 
NAFLD/NASH [12-14] (reviewed by the authors 
[15]), atherosclerosis, myocardial infarction [16, 17] 
and metabolic syndrome [18, 19]. 
Previous studies into the progression of NAFLD have 
used animal models with pre-existing liver damage 
yielding findings with limited physiological 
relevance [20, 21]. We recently used a rat nutritional 
model with fat contents comparable to Western diets. 
Feeding a high-fat diet (71% energy from fat) 
produced type I to II NAFLD compared with the rats 
fed a standard diet (35 % energy from fat) [22]. 
Interestingly, despite similar dietary iron intakes the 
rats fed the standard diet had low hepatic iron content 
compared with rats fed high fat and a stock diet of 
chow [23]. This suggests that in rats fed the standard 
diet, low hepatic iron may protect against the 
development of NAFLD.  
 
In view of this we hypothesized that increased 
hepatic iron in rats fed a standard Western diet would 
progress NAFLD. The aim of this study therefore 
was to feed the standard diet containing normal, 
deficient or twice the normal level of iron plus 
parenteral iron to rats to determine whether hepatic 
iron produced fatty liver via oxidative stress and 
hepatic lipid peroxidation, an indication of NAFLD 
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progression. Plasma lipids were determined to gain 
insight into hepatic lipid loads and potential 
cardiovascular risk. These regimens were selected 
because Western society consumes diets high in fat 
and with different iron bioavailability. Typically, 
vegetarians usually eat diets low in iron 
bioavailability, while others take extra dietary iron as 
supplements or clinically as oral ferrous sulphate or 
as parenteral injections such as iron dextran (eg. 
InferonR).  Since enteric and parenteral iron 
supplements are taken up by hepatocytes and 
macrophages, respectively they were used in the 
present study [24]. In addition, iron loading of both 
cell types is seen in secondary iron overload 
disorders and Type 4 hemochromatosis making this 
study clinically relevant. 
 
2 Methods and Materials 
This study was approved by the Animal Ethics 
Committee, University of Western Australia and all 
animals received humane care. Male Sprague-
Dawley rats 5 weeks of age (135 g) were purchased 
from the Animal Resource Centre (Murdoch WA).  
 
2.1 Animals and diets  
The rats were divided into 3 groups of 10 rats. They 
were housed under controlled conditions (24o C at 
constant humidity of 55% with a 12-h light: dark 
cycle) and given free access to food and water for the 
duration of the study. Diets were purchased from 
Dyets Inc (Bethlehem, PA, USA) in powdered form. 
The diets were made into the consumable liquid form 
each day to avoid lipid peroxidation. The rats were 
fed one of three standard (STD) liquid diets for 5 
weeks. The three diets were isoenergetic and 
identical except in the iron content, which was either 
deficient, 0 mg/L (STD-), normal 8.8 mg/L (STD) or 
twice the normal level 17.5 mg/L (STD+).  The STD 
group was considered as the control group as this 
received the recommended daily iron intake 
recommended by American Institute of Nutrition 
(AIN-93) [25]. The composition of the standard 
liquid diet has been reported previously [23]. 
 
In the liquid form the energy content of the diet 
consisted 35% fat (as dietary fat in the form of corn 
oil, olive oil and safflower oil), 18% protein and 47% 
carbohydrates [26]. This diet was selected because it 
models an average western human diet [27]. During 
the second week the STD+ diet group,  received daily 
intraperitoneal injections of 10 mg iron dextran (100 
mg/ml, Sigma) for 5 days  to iron load macrophages 
[28]. STD- and STD groups were injected with 
vehicle solution.  
 
2.2 Euthanasia 
After 5 weeks on their diets the animals were 
euthanized in a fed state with 0.5 ml intraperitoneal 
pentobarbitone sodium (Nembutal 60 mg/ml 
Boehringer Ingelheim Artamont NSW). Samples of 
blood were taken by cardiac puncture and serum and 
heparinized plasma removed following 
centrifugation. Livers were removed immediately 
after exsanguinations, weighed and about 100 mg of 
the tissue immediately frozen in liquid nitrogen and 
stored at -80oC for RT-PCR analysis. Samples for 
histopathology were fixed in formalin and the 
remaining liver was divided into approximately three 
equal parts, wrapped in cling-plastic and immediately 
frozen at -80oC for later analysis of lipids, iron and 
malondialdehyde (MDA) and 4-hydroxyalkenal 
levels (4-HAE).  
 
2.3 Histological grading of liver 
Formalin fixed and paraffin embedded liver sections 
were stained with haematoxylin and eosin and van 
Gieson’s stain for collagen.  Steatosis was 
determined by frozen section using Oil red O for lipid 
staining. Steatosis was graded according to the 
percentage of hepatocytes containing macrovesicular 
fat (grade 1, 0-25%; grade 2, 26-50%; grade 3, 51-
75%; grade 4, 76-100%) [29]. 
 
2.4 Blood analysis 
Osmotic fragility of erythrocytes was determined as 
described by Senturk et al [30]. The saline 
concentration causing 50 % haemolysis was 
determined graphically using the Graph-Pad Prism 
4.0 program.  
 
2.5 Biochemical analysis 
Serum aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) were measured using a 
serum multiple analyzer (Hitachi 917, Roche 
Diagnostics, Mannheim, Germany).  
 
Serum lipids including total cholesterol, high density 
lipoprotein-cholesterol (HDL-C) and triglycerides 
were measured colorimetrically using commercial 
kits (Thermo Electron Corporation, Noble Park, 
Victoria, Australia).   
 
Plasma non-esterified fatty acids (NEFAs) were 
measured colorimetrically at the Royal Perth Hospital 
by using a NEFA C reagent kit (Novachem Pty. Ltd. 
Victoria, Australia). 
  
2.6 Liver assays 
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Liver samples were thawed on ice and homogenized 
in 1:10 dilution with deionized distilled water. 
Extraction and isolation of lipid to dried lipid extract 
was done using the Folch technique [31]. Hepatic 
cholesterol and triglycerides were enzymatically 
assayed in aliquots of the lipid extract solubilized in 
isopropanol as described above. 
                 
Hepatic MDA and HAE levels were assayed in 
another weighed liver portion. Prior to 
homogenization, 10 µL 0.5M butylated hydroxy 
toluene in acetonitrile was added per 1 ml of 
homogenate to prevent oxidation [32]. Insoluble 
cellular components were removed by centrifugation 
and the cleared supernatant assayed for the MDA and 
HAE aldehydes. When the supernatant was reacted 
with 1 methyl-2-phenylindole in the presence of HCl 
the chromophore generated is MDA specific, whereas 
in the presence of methanesulfonic acid the same 
chromophore reports MDA and HAE aldehydes [33, 
34].  
 
2.7 RT-PCR on liver samples 
2.7.1 RNA isolation and generation of cDNA 
RNA for gene expression studies was isolated from 
liver samples. Approximately 100 mg of tissue were 
homogenized in 1 ml (10 volumes) of TRI Reagent 
(Ambion) and isolated as per the manufacturer’s 
instructions. Quantification and purity of RNA was 
determined by spectrophotometry. Ambion DNA-free 
kit was used to remove genomic DNA from 10 μg of 
RNA. cDNA was generated by reverse transcription 
of aliquots of DNA free RNA using avian 
myeloblastosis virus reverse transcriptase enzyme 
and oligo (dT)15 primers according to the 
manufacturer’s instructions (Promega). cDNA 
products were then purified by using Ultra Clean gel 
spin DNA purification kit (MoBio) and stored at -
20oC for real- time  PCR. 
 
2.7.2 Real-time PCR 
Semiquantitative real-time PCR was performed on a 
Bio-Rad thermal cycler to determine the mRNA 
levels. The PCR mix contained 2 µL of cDNA, 1µM 
of the appropriate forward and reverse primers, 2× 
Quantifast probe PCR Master mix (Qiagen) in a total 
volume of 25 µL. PCR consisted of  50 cycles of 
denaturation at 94oC for 30s, annealing at Tm for 30s, 
and extension at 72oC for 60s. The primer sequences 
for each target gene as well as their optimal PCR 
annealing temperatures are as follows: HO-1[35], 
forward primer 5'-GCCTGCTAGCCTGGTTCAAG-
3' and reverse 5'-AGCGGTGTCTGGGATGAACTA-
3' (Tm 60oC), MTTP1 [36], forward primer 5′-
CACACAACTGGCCTCTCATTAAAT-3′ and 
reverse 5′-TGCCCCCATCGAGAAACACT-3′ (Tm 
60oC), SREBP1c [37], forward primer 5′-
GGAGCCATGGATTGCACATT-3′ and reverse 5′-
AGGAAGGCTTCCAGAGAGGA-3′ (Tm 63oC), 
SREBP 2 [38], forward primer 5′-
CCGGTAATGATGGGCCAAGAG AAA-3′ and 
reverse 5′-AGGCCGGGGGAGACATCAGAAG-3′ 
(Tm 63oC), 7α hydroxylase, forward primer 5′-
CCTTTGGAGAACGGGTTGATT-3′ and reverse 5′-
CAGGGAGTTTGTGATGAAATGG-3′ (Tm 63oC), 
HMG CoA reductase [38], forward primer 5′-
AAGGGGCGTGCAAAGACAATC-3′ and reverse 
5′-ATACGGCACGGAAAGAACCATAGT-3′ (Tm 
63oC), MCP-1[39], forward primer 5’-
CAGATGCAGTTAATGCCCCAC-3’ and reverse 
5’-AGCCGACTCATTGGGATCAT-3’ (Tm 63oC). 
 Primer specificity was confirmed from the product 
size by agarose gel electrophoresis and the specificity 
of the PCR products checked by melt curve analysis. 
 
Relative levels of mRNA were assessed by the fold 
change in the transcript levels calculated relative to 
the first sample as described by Gentle et al [40]. An 
amplification efficiency value of 2 was used for all 
genes. Data are expressed as the fold change per unit 
of β-actin to account for any variations in reverse 
transcriptase efficiency or RNA loading. 
 
2.8 Statistical Analyses 
For statistical analysis Instat (Graph Pad Software, 
San Diego) was used for one way analysis of 
variance (ANOVA). Some data were not normally 
distributed and if the variances were not normalized 
by transformations, non-parametric procedures were 
used as indicated. P < 0.05 was considered 
statistically significant. Results are expressed as 
means ± SEM.  
 
3 Results 
3.1 Osmotic Fragility of Erythrocytes 
The erythrocytes of the STD- group were least fragile 
being able to maintain erythrocyte membrane 
integrity at lower NaCl concentrations compared with 
the STD (P < 0.05) and STD+ groups (P < 0.001). By 
contrast erythrocytes of the STD+ group were 
significantly more fragile compared with erythrocytes 
of the normal iron group (P < 0.001) as shown in 
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Fig.1.
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Measurements STD- STD STD+ 
Log EC50 0.35 
±0.003a*¶  
0.41 ± 
0.002b¶  
0.44 ± 
0.006c 
Hill Slope -9.86 ± 
0.56a§‡ 
-18.63 ± 
3.06b 
-14.13 ± 
1.79b 
Figure 1. Curve analysis of osmotic fragility curves 
for erythrocytes of  iron deficient (STD-), normal 
iron (STD) and iron loaded (STD+) group. Groups 
bearing different superscripts are significantly 
different. The symbols represent statistical 
significance: *p < 0.05 vs STD, ¶p < 0.001 vs 
STD+,§p < 0.05 vs STD+ and ‡p < 0.01 vs STD. 
 
3.2 Liver Enzymes  
 
There were no significant differences in the ALT 
levels between the different groups (Table 1). The 
levels of AST were significantly higher for the STD- 
group compared with the STD group (P < 0.05).  
 
Table 1. Liver enzymes, plasma NEFAs, HDL-
Cholesterol and markers for hepatic lipid 
peroxidation in rats fed standard diet with different 
iron loading 
 
Measurements STD- STD STD+ 
Serum ALT 
(U/L) 
34.3 ± 
1.2 
33.1 ± 
1.5 
29.8 ± 
1.5 
Serum AST 
(U/L) 
174 ± 
10a 
138 ± 
7b 
160 ± 
7ab* 
Serum HDL-C 
(mmol/L) 
1.0 ± 
0.1a 
1.6 ± 
0.1b 
1.9 ± 
0.1c¶ 
Plasma NEFA 
(mmol/L) 
0.41 ± 
0.02a 
0.49 ± 
0.03a  
0.61 ± 
0.03b§ 
MDA 14.87 ± 11.55 ± 17.96 ± 
(nmoles/g liver) 1.65ab 1.75a 1.00b** 
HAE 
(nmoles/g liver) 
15.11 ± 
2.72a 
19.60 ± 
2.60a 
109.68 
± 5.82b§§ 
Groups bearing different superscripts are 
significantly different from each other. The symbols 
represent statistical significance. **P < 0.05 by 
Kruskal-Wallis test, §§P < 0.0001 by Kruskal-Wallis 
test, *P < 0.05, §P < 0.01, ¶P < 0.0001. Data are 
expressed as mean ± SEM. 
 
 
3.3 Plasma Non-esterified fatty acids (NEFAs)  
Plasma NEFA concentration (Table 1) was 
significantly higher in the STD+ group compared 
with STD- and STD groups (P < 0.01). There was no 
significant difference in NEFAs between STD- and 
STD groups. 
 
3.4 Liver Histochemistry  
When the liver was stained with Oil Red O to 
identify lipid droplets, STD- and STD groups showed 
normal liver histology with no evidence of  
micro/macrovesicular steatosis (grade 1), whereas in 
the iron-loaded group (STD+ group) there were foci 
of pronounced periportal macrovesicular lipid 
droplets (zone 1 with 20% hepatocytes showing 
macrovesicular steatosis) (grade 1) (Fig. 2).  
 
When the liver was stained with van Geison’s to 
reveal collagen no increase in collagen deposition 
was seen in any groups.  
 
 
 
Figure 2. Hepatic histology in iron deficient (STD-), 
normal iron (STD) and iron-loaded (STD+) groups 
stained with Oil red O (a,c,e) and hematoxylin and 
eosin (b,d,f). Liver from an iron deficient STD- rat 
showing normal liver histology with minimal fat in 
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hepatocytes (a,b). Livers from the STD group 
showing normal liver architecture.and normal fat 
deposition in hepatocytes (c,d). Iron-loaded STD+ 
group showing foci of periportal lipid droplets 
(marked by arrows) and numerous scattered iron 
laden macrophages (e,f). Magnification × 20. Central 
vein (CV), Portal triad (PT). 
 
 
3.5 Serum Lipids 
Serum total cholesterol and High density lipoprotein-
Cholesterol (HDL-C) levels were significantly 
different between all groups and varied directly with 
body iron stores (P < 0.0001) (Fig. 3 & Table 1). 
Total cholesterol was decreased 29% in the STD- 
compared with the STD group and increased 28% in 
the STD+ group compared with the STD group (Fig. 
3). 
 
Similarly serum triglyceride (TG) level varied 
directly with body iron stores. The STD- group 
showed 47% less TG levels while the STD+ showed 
a 26% increase compared with the STD group (Fig. 
3). 
 
 
 
Figure 3. Serum total cholesterol and triglyceride 
levels in rats fed standard liquid diet with different 
iron loading. Iron deficient (STD-), normal iron 
(STD) and iron-loaded (STD+) groups. Groups 
bearing different superscripts are significantly 
different from each other. The symbols represent 
statistical significance: *P < 0.0001, ¶P < 0.05 after 
logarithmic transformation. Data are expressed as 
mean ± SEM.  
 
3.6 Hepatic Lipids 
There was no statistical difference between the 
various groups in hepatic total cholesterol content 
(Fig. 4 & Fig. 5).  
 
Hepatic triglyceride content was significantly lower 
in STD- compared with STD group and STD+ (P < 
0.01 after logarithmic transformation). There was no 
difference between STD and STD+ groups. 
 
 
 
Figure 4. Hepatic cholesterol and triglyceride content 
in rats fed standard liquid diet with different iron 
loading. Iron deficient (STD-), normal iron (STD) 
and iron-loaded (STD+) groups. Groups bearing 
different superscripts are significantly different from 
each other. The symbols represent statistical 
significance: *P < 0.01 after logarithmic 
transformation. Data are expressed as mean ± SEM. 
 
  
Figure 5. Total hepatic cholesterol and triglyceride 
content per kJ consumed in rats fed standard liquid 
diet with different iron loading. Iron deficient (STD), 
normal iron (STD) and iron-loaded (STD+) groups. 
Groups bearing different superscripts are 
significantly different from each other. The symbols 
represent statistical significance: ¶P < 0.05 after 
logarithmic transformation. Data are expressed as 
mean ± SEM.  
 
3.7 Hepatic lipid peroxidation 
There was no significant difference in hepatic MDA 
and HAE between STD- and STD groups (Table 1). 
In contrast hepatic MDA and HAE levels were 
significantly increased for the STD+ group compared 
with the STD group, MDA levels being 1.5 fold 
higher (P < 0.05 by Kruskal-Wallis test) and HAE 
levels 5.5 fold higher for STD+ group compared with 
STD group (P < 0.0001 by Kruskal-Wallis test). 
 
Table 2. Relative gene expression for different 
groups 
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Genes STD- STD STD+ 
HO-1 1.65 ± 0.55 
 (n=9) 
1.75 ± 0.05 
 (n=3) 
1.77 ± 0.57 
 (n=9) 
SREBP-2 0.94 ± 0.09 
 (n=9) 
0.86 ± 0.11 
 (n=6) 
1.41 ± 0.25 
 (n=9) 
SREBP-1c 0.34 ± 0.07 
 (n=5) 
1.26 ± 0.42  
(n=5) 
0.82 ± 0.22 
 (n=5) 
7α 
hydroxylase 
2.1 ± 0.9 
 (n=4) 
2.7 ± 0.8 
 (n=4) 
3.0 ± 1.0 
(n=5) 
HMG CoA 
reductase 
1.0 ± 0.3 
(n=4) 
1.6 ± 0.4 
 (n=5) 
1.3 ± 0.1 
 (n=5) 
MTTP1 0.48 ± 0.18 
 (n=4) 
0.93 ± 0.23 
 (n=4) 
0.94 ± 0.12 
 (n=5) 
MCP-1 0.53 ± 0.09 
(n=5) 
0.64 ± 0.20 
(n=5) 
0.90 ± 0.36 
(n=5) 
Relative change in mRNA levels in iron deficient 
(STD-), normal iron (STD) and iron-loaded (STD+) 
groups for different genes expression. The mRNA 
gene expression was normalized by dividing the 
value by the β-actin gene expression (house-keeping 
gene). Data are expressed as mean ± SEM. 
 
3.8 Gene Expression 
Semiquantitative real-time PCR for different groups 
are shown in Table 2.  Expression of β-actin gene 
was not significantly different in various groups (data 
not shown) validating its use as a house-keeping 
gene. The expressions of lipid responsive genes 
Sterol regulatory element binding protein-2 and -1c 
(SREBP-2, SREBP-1c), 3-hydroxy-3-methyl glutaryl 
coenzyme A reductase (HMG CoA reductase), 7α 
hydroxylase, microsomal triglyceride transfer protein 
1(MTTP1) chemokine, monocyte chemoattractant 
protein 1 (MCP-1) and oxidative stress indicator, 
haem oxygenase-1 (HO-1) were not significantly 
different among the three groups.  
 
 
4 Discussion 
In this study rats were fed a typical diet found in 
Western society with iron supplementation to test the 
hypothesis that increased liver iron stimulates the 
development of NAFLD. We previously showed in 
these rats that despite a common starting weight the 
final weight of STD- rats along with their daily 
calorie consumption were less than the STD 
(control).  In addition, liver iron an indication of body 
iron stores was decreased 2-fold in the STD- group 
and increased 40-fold in the STD+ group compared 
to the STD group [23]. Therefore, this regimen 
significantly altered body iron stores enabling 
assessment of iron on the development of NAFLD 
[23].  
 
Hepatic TG content was decreased in STD- rats and 
can be explained by reduced calorie intake because 
correction for the amount of calories consumed 
resulted in no significant difference in TG content 
compared with the STD group. In contrast, the STD+ 
group had higher hepatic TG levels than in the STD- 
group even though their calorie intake was similar 
[23]. This suggests the extra iron stimulates 
lipogenesis a finding supported by Oil Red O 
histochemistry revealing foci of pronounced 
periportal macrovesicular lipid droplets in 
hepatocytes. This probably represents the initiation of 
NALFD (NAFLD Type I) in STD+ rats where the 
first “hit” on the liver is thought to involve aberrant 
lipid delivery and utilization (See also below). In 
contrast, other studies using methionine-choline 
deficient (MCD) diet or high sucrose diet to produce 
fatty liver combined with carbonyl iron feeding to 
produce hepatocyte iron overload reported reduced 
hepatic TG levels [20, 41]. This is proposed to be due 
to lipoprotein hyper-secretion and /or defective TG 
uptake in response to lipid peroxidation. The pre-
existing liver damage produced by MCD/sucrose and 
hepatocyte iron overload versus normal liver coupled 
with iron loading of both hepatocytes and 
macrophages used here may explain the differences 
in TG content in these studies. 
 
It is proposed that the advancement of NAFLD 
requires a second hit such as increased oxidative 
stress that stimulate cytokine expression, which in 
turn induces an inflammatory response that replace 
heptocytes by connective tissue . We investigated 
hepatic oxidative stress and lipid peroxidation using 
the biochemical markers HAE and MDA [41-43] and 
found HAE elevated in STD+ rats. We hypothesized 
this might manifest in generalized impaired 
membrane function in STD+ rats by mechanisms 
stated in the introduction. Since erythrocytes are 
exposed to more oxidative stress than most other cell 
types due to plentiful oxygen and heme this may 
manifest in lipid peroxidation [44]. We tested the 
osmotic fragility of erythrocytes in saline and showed 
the erythrocytes of the STD+ group were more 
fragile. This is consistent with increased pro-oxidants 
altering membrane fluidity/stability [42]. It is known 
that MDA cross links erythrocyte phospholipids and 
exposure to oxidants increased erythrocyte membrane 
instability. The increased erythrocyte fragility in the 
STD+ rats appears moderate as there was no 
circulatory hemolysis as evidenced by plasma iron 
being exclusively transferrin-bound [23]. 
  
With respect to the liver of STD+ rats, we found no 
evidence of iron-induced oxidative injury as the 
expression of HO-1 mRNA a sensitive indicator of 
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oxidative stress and a key marker of the antioxidant 
response [42, 45] was similar in all groups. This 
suggests adequate buffering of reactive oxygen 
species by endogenous scavenger systems within the 
liver. Furthermore, to determine whether cytokine 
expression had been affected by iron we measured 
the expression of monocyte chemoattractant protein 
an important regulator of liver fibrosis [46-48]. We 
found no change in MCP-1 mRNA expression across 
the groups indicating an absence of significant liver 
damage and extra collagen deposition, findings 
corroborated by normal serum enzyme levels (ALT 
and AST) and Van Geison’s histochemical staining 
for collagen, respectively. Taken together the foci of 
macrovesicular lipid droplets in the STD+ group 
represent the initiation of the first hit in NAFLD 
development probably due to aberrant lipid delivery 
and processing. In view of this we next considered 
serum lipid levels to gain insight into likely hepatic 
lipid load and cardiovascular risks.  
Serum TGs varied directly with body iron stores and 
confirm previous reports [30, 41, 49]. Very low 
density lipoprotein (VLDL-TG) is the main 
lipoprotein that constitutes total serum TG in the fed 
state [50], although intestinally secreted chylomicrons 
(CM), and their remnants (CMR), also make 
contributions. It is not possible to define the site(s) at 
which iron affects plasma lipoproteins without 
profiling each lipoprotein and their site of 
degradation. Nonetheless, in view of the elevated 
NEFA levels in STD+ rats and the fact they 
substantially contribute to VLDL-TG formation in the 
fed state, we favor increased hepatic lipogenesis and 
hypersecretion of VLDLs in response to increased 
NEFA load. This would explain the increased serum 
TG levels, hepatic TG content and foci of lipid 
droplets in STD+ rats. It is unclear why iron increased 
NEFAs but it is not due to extra calorie intake as this 
was the same as STD- rats.  In the fed state plasma 
NEFA’s are derived from the peripheral 
lipolysis/clearance of lipoproteins, adipose cell 
lipolysis/release, and dietary absorption by the 
intestine [51] and as these sites may be affected by 
iron they should be considered in future work [15, 49] 
. 
 
Serum cholesterol concentration was directly related 
to iron loading. Since the diet was devoid of 
cholesterol, serum cholesterol is derived from 
endogenous sources which in the rat are mainly 
HDL-Cholesterol (HDL-C), but Low density 
lipoprotein-Cholesterol (LDL-C) and VLDL-
Cholesterol (VLDL-C) contribute about 33% [52]. 
Serum cholesterol reflects the integration of a number 
of pathways involved in lipid metabolism involving 
its uptake, synthesis, catabolism and secretion. 
Although others have shown that some of these 
pathways are affected by variations in iron [53-55] 
we saw no change in hepatic mRNA levels for genes 
involved with cholesterol metabolism (SREBP-2 and 
-1c), its synthesis (HMG CoA reductase) and its 
catabolism (7α hydroxylase). Others have shown 
reduced cholesterol synthesis [53, 56] and HDL-C 
[53, 57], indicating a role for iron in post-
transcriptional regulation of cholesterol metabolism.  
 
It is known that LDL-C is subject to oxidation [58] 
and is taken up by vascular macrophages to form 
foam cells that contribute to atherosclerotic 
lesions/plaques[59, 60]. Given the high serum 
cholesterol coupled with a raised pro-oxidant 
environment of the vascular system due to iron-laden 
macrophages the increased erythrocyte fragility in 
STD+ rats indicates an increased risk to 
atherosclerotic lesions in this group as shown by 
others [16, 61].  
 
The inclusion of lipoprotein profiling, and absorptive 
studies of dietary fats with variations in iron would 
have provided an additional insight in these 
mechanisms. In summary, our hypothesis that iron 
contributes to NAFLD is supported by showing in 
STD+ rats impaired hepatic fat metabolism as 
evidenced by isolated foci of macrovesicular lipid 
droplets probably due to increased hepatic lipid load 
but hepatic oxidative stress produced by iron appears 
buffered by adequate cellular antioxidants. Also in 
STD+ rats erythrocyte fragility indicates a risk to 
atherosclerosis given the high serum cholesterol and 
iron-laden macrophages. This regimen offers an 
opportunity to study the early stages in the 
development towards NAFLD and other risk factors.  
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